- Home
- ONB vs RVMD Comparison
ONB vs RVMD Comparison
Compare ONB & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONB
- RVMD
- Stock Information
- Founded
- ONB 1834
- RVMD 2014
- Country
- ONB United States
- RVMD United States
- Employees
- ONB N/A
- RVMD N/A
- Industry
- ONB Major Banks
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONB Finance
- RVMD Health Care
- Exchange
- ONB Nasdaq
- RVMD Nasdaq
- Market Cap
- ONB 7.6B
- RVMD 7.5B
- IPO Year
- ONB N/A
- RVMD 2020
- Fundamental
- Price
- ONB $22.76
- RVMD $37.87
- Analyst Decision
- ONB Buy
- RVMD Strong Buy
- Analyst Count
- ONB 9
- RVMD 12
- Target Price
- ONB $26.11
- RVMD $68.67
- AVG Volume (30 Days)
- ONB 3.0M
- RVMD 3.1M
- Earning Date
- ONB 07-22-2025
- RVMD 08-06-2025
- Dividend Yield
- ONB 2.46%
- RVMD N/A
- EPS Growth
- ONB N/A
- RVMD N/A
- EPS
- ONB 1.72
- RVMD N/A
- Revenue
- ONB $1,795,802,000.00
- RVMD N/A
- Revenue This Year
- ONB $44.36
- RVMD N/A
- Revenue Next Year
- ONB $16.12
- RVMD $241.39
- P/E Ratio
- ONB $13.24
- RVMD N/A
- Revenue Growth
- ONB 3.29
- RVMD N/A
- 52 Week Low
- ONB $16.50
- RVMD $29.17
- 52 Week High
- ONB $24.49
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- ONB 68.49
- RVMD 44.16
- Support Level
- ONB $21.16
- RVMD $36.65
- Resistance Level
- ONB $21.70
- RVMD $38.18
- Average True Range (ATR)
- ONB 0.49
- RVMD 1.52
- MACD
- ONB 0.21
- RVMD -0.31
- Stochastic Oscillator
- ONB 91.79
- RVMD 29.10
About ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.